Language selection

Search


Audit of the Biologics and Radiopharmaceutical Drugs Program at Health Canada, June 2018.H14-604/2018E-PDF

"We examined the management control framework related to the Biologics and Radiopharmaceutical Drugs Program (BRDP or the Program). The audit focused on governance, risk management, and internal controls..."--Executive Summary, page [4].

Permanent link to this Catalogue record:
publications.gc.ca/pub?id=9.937142&sl=0

Publication information
Department/Agency
  • Canada. Health Canada, issuing body.
  • Public Health Agency of Canada, issuing body.
TitleAudit of the Biologics and Radiopharmaceutical Drugs Program at Health Canada, June 2018.
Publication typeMonograph
Language[English]
Other language editions[French]
FormatDigital text
Electronic document
Note(s)
  • Issued also in French under title: Audit du programme des produits biologiques et radiopharmaceutiques de Santé Canada, juin 2018.
  • "Final report presented to the Departmental Audit Committee, June 20, 2018."
Publishing information
  • [Ottawa] : Health Canada and the Public Health Agency of Canada = Santé Canada et l'Agence de la santé publique du Canada, June 20, 2018.
Description1 online resource (27 unnumbered pages) + management response and action plan (5 unnumbered pages)
Catalogue number
  • H14-604/2018E-PDF
Subject terms
Request alternate formats
To request an alternate format of a publication, complete the Government of Canada Publications email form. Use the form’s “question or comment” field to specify the requested publication.

Page details